ОбзорГрафикПрофильОсновная статистикаФинансовые показателиНовости
Деривативы
TraderScreen

MERCK CO. DL-,01/  US58933Y1055  /

Lang & Schwarz
09.11.2024  13:04:45 Изменение -0.200 Объем сделки Бид13:04:45 Предложение13:04:45 Рыночная капитализация Дивидендная доходность Коэффициент Цена/Доход
95.800EUR -0.21% -
Оборот: -		 95.800Величина цены спроса: - 96.500Величина цены предложения: - 242.92 млрдEUR - -
TeleTrader 31.10 Merck's Q3 sales up 4% to $16.7 billion
GlobeNewswire 31.07 Vaccinex Reports Positive Data for SIGNAL-AD Phase 1b/2 trial of Pepinemab in Alzheimer’s Disease
TeleTrader 30.07 Merck falls 7% after Q2 earnings report
TeleTrader 30.07 Merck's Q2 sales up 7% to $16.1 billion
GlobeNewswire 17.07 Vaccinex to report topline data for SIGNAL-AD Phase 1b/2 trial of Pepinemab in Alzheimer’s Disease a...
GlobeNewswire 09.07 Prelude Therapeutics Announces Clinical Collaboration with Merck to Evaluate PRT3789 in Combination ...
GlobeNewswire 27.06 Verizon elects Caroline A. Litchfield to its Board of Directors
GlobeNewswire 27.06 Arch Biopartners Announces GMP Manufacturing of Cilastatin Drug Product
GlobeNewswire 25.06 Qure.ai announces strategic investment by Merck Global Health Innovation Fund to boost innovation of...
GlobeNewswire 18.06 Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for ...
GlobeNewswire 06.06 Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepin...
GlobeNewswire 05.06 Coherus BioSciences Appoints Rita Karachun, CPA, CGMA to its Board of Directors
GlobeNewswire 03.06 Biolojic Design Enters into a Multi-Target Drug Discovery Collaboration with Merck KGaA, Darmstadt, ...
TeleTrader 29.05 Merck to buy biotech firm EyeBio for up to $3B
GlobeNewswire 29.05 Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio fo...
GlobeNewswire 29.05 Anaveon announces IND approval of ANV600-001 (EXPAND) Phase I/II clinical study
GlobeNewswire 07.05 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire 06.05 Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire 02.05 Cerevance Achieves First Milestone in Research Collaboration with Merck
TeleTrader 25.04 Merck's Q1 sales rise by 9% to $15.8 billion
GlobeNewswire 02.04 Vaccinex Reports 2023 Financial Results and Provides Corporate Update
GlobeNewswire 06.03 IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Can...
GlobeNewswire 04.03 C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
TeleTrader 02.02 Merck Group to expand investment in South Korea
TeleTrader 01.02 Merck's Q4 sales up 6% to $14.6B